CTOs on the Move

Motion Concepts Canada

www.motionconcepts.com

 
Motion Concepts Canada is a Concord, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Deltex Medical

Deltex Medical is a Greenville, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hilton East Assisted Living

Hilton East Assisted Living is a 205 bed community nestled in the peaceful village of Hilton , NY. Our staff has a track record of quality care that spans over 30 years. We have been providing impeccable care since 1974. We provide more care hours per

Pivot Health Solutions

Pivot Health Solutions is the parent company of Pivot Physical Therapy, Pivot Occupational Health, Pivot Sports Medicine, and Pivot Performance. With over 2,500 employees offering health and wellness services through our family of brands located throughout the United States, we are committed to being a dedicated, trustworthy, and caring leader focused on getting patients back to their healthy lives. From athletes looking to improve their performance to employees experiencing a workplace injury, our clinicians provide one-on-one care by creating personalized care plans to get individuals back to healthiness. We are The Healthiness People.

VieMed

Viemed is a provider of in-home medical equipment and post-acute respiratory healthcare services in the United States. Viemed`s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counseling to patients in their homes using cutting edge technology.

Immune Pharmaceuticals

Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma. The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells. The Company’s growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors. Immune is headquartered in the U.S., with its primary research and development facilities in Israel.